Teri Loxam | IR & Global Communications |
Ken Frazier | Chairman and Chief Executive Officer |
Rob Davis | Chief Financial Officer |
Adam Schechter | President of Global Human Health |
Dr. Roger Perlmutter | President of Merck Research Labs |
Steve Scala | Cowen |
Andrew Baum | Citi |
Jami Rubin | Goldman Sachs |
Chris Schott | JPMorgan |
Vamil Divan | Credit Suisse |
David Risinger | Morgan Stanley |
Gregg Gilbert | Deutsche Bank |
Jason Gerberry | Bank of America |
John Boris | SunTrust |
Alex Arfaei | BMO Capital Markets |
Good morning. My name is Doherty, and I will be your conference operator today. At this time, I would like to welcome everyone to Merck's Second Quarter 2018 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.